منبع: Zacks Investment Research
خبرگزاری
سهام
اهمیت متوسط
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates
Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss of $0.83 per share a year ago.
نمادهای مرتبط
1
S
SNDX
SNDX
منبع: Zacks Investment Research
مشاهده منبع